HCV treatment
Direct Acting Antivirals Improve HCV Treatment Initiation and Adherence Among Underserved African Americans
... on HCV treatment eligibility, initiation, and adherence to HCV care in a HCV-infected African American population accessing care in a liver specialty clinic within a safety-net healthcare sys- ...
6
Current concepts in the management and treatment of hepatitis C in HIV infected patients
... with HCV has been acknowledged over the last ...garding treatment monitoring, the stopping rule at week 12 recommended for HCV-monoinfected indi- viduals, seems to be equally valid in HIV-infected ...
11
Survival of hepatitis C infected haemophilia patients is predicted by presence of cirrhosis but not by anti viral treatment
... untreated HCV-infected haemophilia ...sub-groups: HCV mono-infected (N = 127), HCV/HIV co-infected (N = 28), and patients with either HCV-antibodies negative or persistent HCV ...
9
Aplastic Anemia and Severe Myelosuppression with Boceprevir or Simeprevir Containing Hepatitis C Virus Treatment
... x109/L. HCV treatment was discontinued and red blood cells and platelet transfusions were ...antiviral treatment as the most plausi- ble cause of hematological toxicity in this ...case. ...
6
Peginterferon alpha 2b plus ribavirin for chronic hepatitis C virus mixed genotype infection
... 204 HCV patients assigned to treat with peginterferon and ribavirin, the percentage of HCV genotypes and subtypes analysis were genotype 1 ...20, HCV treatment relapse cases, drug with ...
6
Reasons for HCV non treatment in underserved African Americans: Implications for treatment with new therapeutics
... for HCV non-treatment among underserved African Americans in a large safety- net ...of HCV-infected African Americans evaluated at San Francisco General Hospital liver specialty clinic from 2006-2011 ...
9
Distribucin agrupada de las clulas infectadas por el virus en el hgado de pacientes con hepatitis C crnica
... for HCV-RNA of both positive and negative polaritywere detected in the cytoplasm of hepatocytes from most of the samples ...of HCV RNA and the HCV treatment. In addition, HCV RNA was ...
12
Analysis of hepatitis C virus (HCV) RNA load in platelets of HCV monoinfected patients receiving antiviral therapy
... Paired samples of serum and platelets were collected from 17 patients at baseline and at longi- tudinal timepoints of antiviral treatment (at week 12, end-of-treatment, and 24 weeks after completion of ...
7
A rational use of laboratory tests in the diagnosis and management of hepatitis C virus infection
... of HCV infection is very diversified according to geographical areas and ranges from 1% in the Northern regions of the world to more than 20% as we move ...of HCV- associated liver diseases and the ...
9
Faldaprevir, pegylated interferon, and ribavirin for treatment nave HCV genotype 1: pooled analysis of two phase 3 trials
... in treatment-naïve pa- tients with HCV GT-1 infection, and that faldaprevir 120 mg and 240 mg were equally ...mg treatment arm compared with the 240 mg ...of HCV research and demonstrate the ...
17
Efficacy of triple therapy with thymalfasin, peginterferon α 2a, and ribavirin for the treatment of hispanic chronic HCV nonresponders
... In conclusion, our data indicate that the triple therapy regimen including thymalfasin/ PEG IFN α -2a/ribavirin offers advantages for the re-treatment of genotype 1 non- responders. Both initial response and ...
7
Lexico grammatical aspects of the translation of a medical research paper about hepatitis
... In clinical practice, it is most important to identify persons who are currently infected; however, for surveillance purposes, we are interested in having a reliable measure of both those who are currently infected and ...
59
Current and future treatment options for HCV
... with HCV genotype 1 or 2/3, respec- ...during treatment, individu- alization of treatment duration is ...new HCV specific inhibitors against the NS3/4A polymerase and the NS5B poly- ...with ...
10
Non invasive assessment of liver steatosis and fibrosis in HIV/HCV and HCV infected patients
... the independent association between triglycerides and steatosis in either of the HCV-groups, suggests that dietary interventions and lifestyle changes should be proposed to these patients in order to reduce ...
9
Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV infected patients
... Approximately 1% of HIV-infected patients in this study had both HBsAg and anti-HCV. These triply in- fected patients were disproportionately male (2.2% of males vs 0.4% of females). Although the absolute number ...
5
Estudio comparativo de dos pruebas para determinar carga viral para VIH 1 y VHC basadas en RT PCR de tiempo real
... También se analizó el impacto de la prueba Ab- bott RealTime HCV Test en los pacientes que pre- sentaban una carga viral previa indetectable mediante la prueba COBAS AMPLICOR HCV Monitor Test v2.0; de 14 ...
10
Treatment of Chronic HCV Infection with the New Direct Acting Antivirals (DAA): First Report of a Real World Experience in Southern Brazil
... had treatment prematurely interrupted for any reason were considered treatment failure in this intention to treat ...were treatment ex- ...7 treatment experienced, and 6 either genotype 3 or ...
7
The Observed Effect of Gastric Bypass Surgery on Direct acting Antiviral Treatment: a Case Report
... were 97% lower than comparable reference values, and the AUC 0-24 was 84% lower. Our patient was not able to have large or “normal sized” meals (i.e. a high intake of calo- ries) anymore and we postulate that this ...
5
Hypovitaminosis D and its relation to demographic and laboratory data among hepatitis C patients
... in HCV infection remains ...among HCV infected individuals and to evaluate the association be- tween vitamin D status, virological response, and laboratory ...chronic HCV infected patients (139 ...
7
Protease inhibitor based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experience
... recurrent HCV in Genotype 1 (G1) LT recipients have been disappointing ...G1 HCV recurrence with either BOC (n = 41) or TVR (n = 35), who were non-respon- ders or relapsers (n = 54), treatment naïve ...
8